Evaluation of anti-SIV potential of anti-neoplastic anthracyclines.
Wuu
J
J
Department of Medical Pharmacology & Toxicology, School of Medicine, University of California, Davis 95616.
Chuang
L F
LF
Blackbourn
D J
DJ
Killam
K F
KF
Israel
M
M
Chuang
R Y
RY
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D000956:Antigens, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D018894:Reverse Transcriptase Inhibitors; D015302:Simian Immunodeficiency Virus / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology
D000903:Antibiotics, Antineoplastic; D000956:Antigens, Viral; D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors